StockData
Faeth Therapeutics, Inc. logo

Faeth Therapeutics, Inc. (FTH) stock

FTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30
$9.04−0.24 (-2.59%)

Close on Nov 17, 2026Market cap $233.60MP/E –Yield –

Faeth Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Faeth Therapeutics

Faeth Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Faeth Therapeutics figures

See a number that looks wrong?